Superworth

Immunic EPS IMUX

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$4.18
Latest quarter, Q2 FY26
−$0.80
Fiscal year 2025
−$6.84

Immunic's earnings per share was −$4.18 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.80.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$6.84n/a
FY2024−$10.00n/a
FY2023−$21.10n/a
FY2022−$36.30n/a
FY2021−$40.20n/a
FY2020−$29.20n/a
FY2019−$81.80n/a
FY2018−$136.20n/a
FY2017−$532.00n/a
FY2016−$520.00n/a
FY2015−$840.00n/a
FY2014−$10632.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.80n/a−$4.18
Q1 FY26−$1.08n/a−$5.41
Q4 FY25−$1.00n/a−$6.84
Q3 FY25−$1.30n/a−$8.34
Q2 FY25−$2.03n/a−$9.44
Q1 FY25−$2.51n/a−$9.51
Q4 FY24−$2.50n/a−$10.00
Q3 FY24−$2.40n/a−$12.30
Q2 FY24−$2.10n/a−$15.00
Q1 FY24−$3.00n/a−$18.30
Q4 FY23−$4.80n/a−$21.10
Q3 FY23−$5.10n/a−$31.10

Against its peers

Companies in Drug Manufacturers - General nearest Immunic's size, closest first, today.

CompanyEPS, 12 monthsGrowth
IMUXImmunic−$4.18
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
NATRNatures Sunshine Products$1.01+36% a year
ATNMActinium Pharmaceuticals$0.36
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Immunic

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.